Two-stage Augmentation for Detecting Malignancy of BI-RADS 3 Lesions in Early Breast Cancer

Author:

Tian Huanhuan1,Cai Li1,Gui Yu2,Cai Zhigang1,Han Xianfeng1,Liao Jianwei1,Chen Li2,Wang Yi1

Affiliation:

1. Southwest University

2. Southwest Hospital of Third Military Medical University

Abstract

Abstract Objectives In view of inherent attributes of breast BI-RADS 3, benign and malignant lesions are with a subtle difference and the imbalanced ratio (with a very small part of malignancy). The objective of this study is to improve the detection rate of BI-RADS 3 malignant lesions on breast ultrasound (US) images using deep convolution networks. Methods In the study, 1,275 lesions out of 1,096 patients were included from Southwest Hospital (SW) and Tangshan Hospital (TS). In which, 629 lesions, 218 lesions and 428 lesions were utilized for the development dataset, the internal and external testing set. All lesions were confirmed with ground truth of three-year follow-up benign or biopsy benign/malignancy, and each lesion had both B-mode and color Doppler images. We proposed a two-step augmentation method, covering malignancy feature augmentation and data augmentation, and further verified the feasibility of our augmentation method on a dual-branches ResNet50 classification model named Dual-ResNet50. We conducted a comparative analysis between our model and four radiologists in breast imaging diagnosis. Results After malignancy feature and data augmentations, our model achieved a high area under the receiver operating characteristic curve (AUC) of 0.881(95% CI: 0.830-0.921), the sensitivity of 77.8% (14/18), in the SW test set, and an AUC of 0.880 (95% CI: 0.847-0.910), a sensitivity of 71.4% (5/7) in the TS test set. In the comparison set, our model outperformed four radiologists with more than 10-years of diagnosis experience. Our method improved the cancer detection rate of BI-RADS 3 lesions, thereby aiding in a timely adjustment of subsequent treatment for these patients in the early stage. Conclusions The results demonstrated that our proposed augmentation method can help the deep learning (DL) classification model to improve the breast cancer detection rate in BI-RADS 3 lesions.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3